(Q41389100)

30 September 2017

title

Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease (English)

1 reference

30 September 2017

1 reference

Lee BY

1

1 reference

30 September 2017

Berkowitz P

2

1 reference

30 September 2017

Savitsky JP

3

1 reference

30 September 2017

May GS

4

1 reference

30 September 2017

Brobst J

5

1 reference

30 September 2017

McCann WJ Jr

6

1 reference

30 September 2017

publication date

1 March 1985

1 reference

30 September 2017

1 reference

30 September 2017

volume

8

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

161-165

1 reference

Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960080308

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960080308

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960080308

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CLC.4960080308

1 reference

30 September 2017

1 reference